Company No: SC607832 (Scotland)

Contents

• Balance Sheet
• Notes to the Financial Statements

	Note	2025		2024
		£		£
Fixed assets		84,774		114,218
Current assets		449,717		18,573
Prepayments and accrued income		68,014		855
Creditors: amounts falling due within one year		( 288,991)		( 128,326)
Net current assets/(liabilities)		228,740		( 108,898)
Total assets less current liabilities		313,514		5,320
Creditors: amounts falling due after more than one year	3	( 557,745)		( 1,620)
Accruals and deferred income		( 11,752)		-
Net (liabilities)/assets		( 255,983)		3,700
Capital and reserves		( 255,983)		3,700

For the financial year ending 30 September 2025 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

• The members have not required the Company to obtain an audit of its financial statements for the financial year in accordance with section 476;
• The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements;
• These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and FRS 105 The Financial Reporting Standard applicable to the Micro-entities Regime;
• These financial statements have been delivered in accordance with the small companies regime and a copy of the Profit and Loss Account has not been delivered.

The financial statements of Origin Peptides Limited (registered number: SC607832) were approved and authorised for issue by the Board of Directors on 11 May 2026 and were signed on its behalf by:

Mr G Buchanan Director

1. Company information

The Company is a private company limited by shares and is incorporated in the United Kingdom and registered in Scotland (Company no. SC607832). The address of its registered office is 8 St. Magdalenes, Linlithgow, EH49 6AQ, Scotland, United Kingdom.

2. Employees

	2025		2024
	Number		Number
Monthly average number of persons employed by the Company during the financial year, including directors	5		4

3. Creditors: amounts falling due after more than one year

Convertible loan notes

Included within creditors due after more than one year are unsecured convertible loan notes of USD 750,000. The convertible loan notes are interest-free and repayable five years from the date of issue, unless converted or redeemed earlier in accordance with the terms of the instrument.

4. Going Concern

The company has made a loss for the year, which is in line with the directors’ expectations. The company has access to sufficient funding and cash resources to meet its day-to-day working capital requirements.

The directors have considered a period of at least 12 months from the date of approval of the financial statements and believe that the going concern basis of preparation remains appropriate.